Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;53(5):693-700.
doi: 10.2967/jnumed.111.099127. Epub 2012 Mar 27.

Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET

Affiliations

Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET

Florent Tixier et al. J Nucl Med. 2012 May.

Abstract

(18)F-FDG PET measurement of standardized uptake value (SUV) is increasingly used for monitoring therapy response and predicting outcome. Alternative parameters computed through textural analysis were recently proposed to quantify the heterogeneity of tracer uptake by tumors as a significant predictor of response. The primary objective of this study was to evaluate the reproducibility of these heterogeneity measurements.

Methods: Double baseline (18)F-FDG PET scans were acquired within 4 d of each other for 16 patients before any treatment was considered. A Bland-Altman analysis was performed on 8 parameters based on histogram measurements and 17 parameters based on textural heterogeneity features after discretization with values between 8 and 128.

Results: The reproducibility of maximum and mean SUV was similar to that in previously reported studies, with a mean percentage difference of 4.7% ± 19.5% and 5.5% ± 21.2%, respectively. By comparison, better reproducibility was measured for some textural features describing local heterogeneity of tracer uptake, such as entropy and homogeneity, with a mean percentage difference of -2% ± 5.4% and 1.8% ± 11.5%, respectively. Several regional heterogeneity parameters such as variability in the intensity and size of regions of homogeneous activity distribution had reproducibility similar to that of SUV measurements, with 95% confidence intervals of -22.5% to 3.1% and -1.1% to 23.5%, respectively. These parameters were largely insensitive to the discretization range.

Conclusion: Several parameters derived from textural analysis describing heterogeneity of tracer uptake by tumors on local and regional scales had reproducibility similar to or better than that of simple SUV measurements. These reproducibility results suggest that these (18)F-FDG PET-derived parameters, which have already been shown to have predictive and prognostic value in certain cancer models, may be used to monitor therapy response and predict patient outcome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Illustration of one of the tumors considered in this study (sagittal slice) for varying discretization values (from 8 to 128 distinct values).
Figure 2
Figure 2
Bland-Altman plots of intensity histogram parameters: SUVmax (A) and kurtosis (B); as well as textural features heterogeneity parameters: entropy (C) and size-zone variability (D). Lines show combined mean, 95%CI, as well as upper and lower reproducibility limits
Figure 3
Figure 3
Plots showing the standard deviation of the mean percentage difference as a function of the discretization value for parameters derived from co-occurrences matrices (entropy, dissimilarity, contrast) (A) and intensity size-zone matrices (LISAE: Low-intensity small-area emphasis, SZV: Size-zone variability, ZP: zone percentage) (B).

Comment in

References

    1. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(suppl 1):122S–150S. - PMC - PubMed
    1. Cazaentre T, Morschhauser F, Vermandel M, et al. Pre-therapy 18F PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma. Eur J Nucl Med Mol Imaging. 2010;37:494–504. - PubMed
    1. Rizk NP, Tang L, Adusumilli PS, et al. Predictive value of initial PET SUVmax in patients with locally advanced esophageal and gastroesophageal junction adenocarcinoma. J Thoracic Oncol. 2009;4:875–879. - PubMed
    1. Leibold T, Akhurst TJ, Chessin DB, et al. Evaluation of (18)F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis. Ann Surg Oncol. 2011;18:2783–2789. - PMC - PubMed
    1. Shamim SA, Kumar R, Shandal V, et al. FDG PET/CT evaluation of treatment response in patients with recurrent colorectal cancer. Clin Nucl Med. 2011;36:11–16. - PubMed

Publication types

MeSH terms

Substances